Scholarly Index
Jeremy N. Rich
University of North Carolina at Chapel Hill; 59,785 total citations; 550 total publications; best world rank #8
University of North Carolina at Chapel Hill
59,785Total citations
550Total publications
126H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Cells and Metastasis | Lifetime | 8 | US 6 | 99.92 |
| Glioma Diagnosis and Treatment | Lifetime | 34 | US 25 | 99.87 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 53 | US 28 | 99.75 |
| Epigenetics and DNA Methylation | Lifetime | 109 | US 69 | 99.60 |
| FOXO transcription factor regulation | Lifetime | 17 | US 13 | 98.23 |
| MicroRNA in disease regulation | Lifetime | 592 | US 170 | 98.13 |
| Brain Metastases and Treatment | Lifetime | 227 | US 144 | 98.27 |
| Histone Deacetylase Inhibitors Research | Lifetime | 328 | US 179 | 96.86 |
| Neuroblastoma Research and Treatments | Lifetime | 661 | US 324 | 96.81 |
| Cancer Research and Treatments | Lifetime | 947 | US 481 | 95.91 |
| Cancer Mechanisms and Therapy | Lifetime | 504 | US 218 | 95.14 |
| Protein Degradation and Inhibitors | Lifetime | 689 | US 339 | 95.46 |
| TGF-β signaling in diseases | Lifetime | 380 | US 180 | 94.81 |
| Glioma Diagnosis and Treatment | 2021-2025 | 880 | US 355 | 93.13 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 952 | US 204 | 86.30 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 454 | US 127 | 62.97 |
| Caveolin-1 and cellular processes | 2021-2025 | 430 | US 121 | 31.70 |